Agios Pharmaceuticals Quarterly Balance Sheets Chart
Quarterly
|
Annual
Agios Pharmaceuticals Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 80,871,000 | 78,964,000 | 76,247,000 | 253,730,000 | 84,518,000 | 118,764,000 | 88,205,000 | 64,333,000 | 84,753,000 | 104,139,000 | 139,259,000 | 122,449,000 | 88,543,000 | 80,026,000 | 203,126,000 | 400,224,000 | 969,124,000 | 1,888,025,000 | 127,436,000 | 104,855,000 | 295,858,000 | 89,093,000 | 80,931,000 | 81,709,000 | 83,580,000 | 103,443,000 | 70,502,000 | 156,478,000 | 210,323,000 | 364,469,000 | 102,724,000 | 132,741,000 | 138,717,000 | 200,278,000 | 160,754,000 | 285,502,000 | 234,048,000 | 39,035,000 | 71,764,000 | 80,048,000 | 72,533,000 | 35,256,000 | 14,031,000 | 70,049,000 | 108,247,000 | 32,837,000 | 71,560,000 | 106,011,000 | 77,481,000 |
| marketable securities | 858,066,000 | 814,411,000 | 817,463,000 | 751,027,000 | 485,374,000 | 479,227,000 | 688,723,000 | 583,155,000 | 617,813,000 | 635,062,000 | 643,860,000 | 605,231,000 | 730,766,000 | 843,503,000 | 816,892,000 | 865,833,000 | 703,864,000 | 447,578,000 | 445,493,000 | 500,684,000 | 494,270,000 | 439,528,000 | 483,946,000 | 370,188,000 | 411,810,000 | 421,114,000 | 514,800,000 | 513,414,000 | 506,582,000 | 417,981,000 | 321,212,000 | 375,187,000 | 447,325,000 | 279,480,000 | 380,560,000 | 293,595,000 | 231,321,000 | 273,859,000 | 245,238,000 | 272,317,000 | 297,261,000 | 309,450,000 | 328,034,000 | 149,921,000 | 130,233,000 | 129,432,000 | 95,209,000 | 88,945,000 | 21,794,000 |
| accounts receivable | 4,986,000 | 3,344,000 | 4,109,000 | 3,118,000 | 3,762,000 | 3,453,000 | 2,810,000 | 1,176,000 | 2,251,000 | 1,778,000 | 2,206,000 | 1,818,000 | 1,598,000 | 540,000 | 21,328,000 | 18,989,000 | 12,023,000 | 11,813,000 | 8,952,000 | 7,106,000 | 7,147,000 | 4,355,000 | 5,076,000 | 2,631,000 | |||||||||||||||||||||||||
| inventory | 30,848,000 | 29,605,000 | 27,616,000 | 26,429,000 | 23,937,000 | 23,070,000 | 19,076,000 | 17,274,000 | 15,671,000 | 11,374,000 | 8,492,000 | 5,176,000 | 4,060,000 | 2,485,000 | 14,698,000 | 11,371,000 | 11,231,000 | 9,778,000 | 7,331,000 | 5,849,000 | 4,659,000 | 2,328,000 | 869,000 | 863,000 | |||||||||||||||||||||||||
| prepaid expenses and other current assets | 44,693,000 | 42,292,000 | 40,165,000 | 39,885,000 | 34,536,000 | 39,113,000 | 35,021,000 | 38,414,000 | 36,751,000 | 39,303,000 | 38,955,000 | 46,487,000 | 42,336,000 | 43,226,000 | 39,835,000 | 32,238,000 | 21,443,000 | 19,511,000 | 23,651,000 | 28,861,000 | 26,959,000 | 29,152,000 | 24,177,000 | 19,985,000 | 19,063,000 | 19,696,000 | 17,167,000 | 16,458,000 | 15,538,000 | 15,614,000 | 17,486,000 | 15,316,000 | 13,018,000 | 12,391,000 | 10,264,000 | 10,277,000 | 8,923,000 | 9,190,000 | 8,728,000 | 7,225,000 | 4,602,000 | 5,512,000 | 4,814,000 | 4,990,000 | 2,842,000 | 3,033,000 | 2,502,000 | 2,616,000 | 2,011,000 |
| total current assets | 1,019,464,000 | 968,616,000 | 965,600,000 | 1,074,189,000 | 632,127,000 | 663,627,000 | 833,835,000 | 704,352,000 | 757,239,000 | 791,656,000 | 832,772,000 | 784,935,000 | 870,007,000 | 975,145,000 | 1,064,231,000 | 1,305,285,000 | 1,702,562,000 | 2,355,114,000 | 636,677,000 | 669,086,000 | 846,355,000 | 587,274,000 | 611,704,000 | 490,144,000 | 533,705,000 | 557,095,000 | 613,780,000 | 695,542,000 | 753,782,000 | 802,993,000 | 445,261,000 | 528,307,000 | 604,681,000 | 506,866,000 | 559,892,000 | 600,943,000 | 484,159,000 | 329,469,000 | 337,329,000 | 371,660,000 | 390,152,000 | 364,141,000 | 359,546,000 | 247,560,000 | 245,163,000 | 172,417,000 | 169,747,000 | 198,818,000 | 102,533,000 |
| operating lease assets | 36,785,000 | 39,861,000 | 42,879,000 | 45,841,000 | 48,750,000 | 51,606,000 | 54,409,000 | 57,162,000 | 59,866,000 | 62,521,000 | 65,129,000 | 67,692,000 | 70,214,000 | 72,688,000 | 75,124,000 | 77,532,000 | 79,901,000 | 82,244,000 | 84,661,000 | 86,952,000 | 89,208,000 | 91,440,000 | 93,643,000 | 95,833,000 | 98,500,000 | 57,768,000 | |||||||||||||||||||||||
| property and equipment | 10,579,000 | 11,067,000 | 11,675,000 | 11,819,000 | 12,726,000 | 14,119,000 | 15,382,000 | 16,785,000 | 19,634,000 | 21,438,000 | 22,987,000 | 25,438,000 | 27,382,000 | 29,195,000 | 28,923,000 | 25,342,000 | 27,056,000 | 28,976,000 | 32,291,000 | 33,495,000 | 33,925,000 | 33,840,000 | 31,472,000 | 24,060,000 | 23,016,000 | 23,974,000 | 24,320,000 | 24,613,000 | 24,134,000 | 23,732,000 | 24,431,000 | 24,019,000 | 24,771,000 | 24,139,000 | 25,337,000 | 26,261,000 | 25,134,000 | 22,950,000 | 23,220,000 | 21,127,000 | 19,328,000 | 14,297,000 | 6,386,000 | 3,677,000 | 3,210,000 | 3,452,000 | 3,758,000 | 3,551,000 | 3,818,000 |
| other non-current assets | 3,942,000 | 4,721,000 | 4,724,000 | 4,056,000 | 4,056,000 | 4,056,000 | 4,057,000 | 4,057,000 | 4,057,000 | 3,956,000 | 3,956,000 | 3,903,000 | 3,955,000 | 2,900,000 | 2,900,000 | 2,900,000 | 2,900,000 | 1,125,000 | 60,000 | 238,000 | 416,000 | 595,000 | 1,104,000 | 891,000 | 1,070,000 | 1,249,000 | 2,888,000 | 1,615,000 | 1,339,000 | ||||||||||||||||||||
| total assets | 1,471,237,000 | 1,555,518,000 | 1,663,199,000 | 1,791,794,000 | 773,063,000 | 849,709,000 | 937,118,000 | 1,007,258,000 | 1,085,153,000 | 1,151,298,000 | 1,238,718,000 | 1,180,320,000 | 1,252,467,000 | 1,335,859,000 | 1,437,736,000 | 1,541,498,000 | 1,874,603,000 | 2,488,434,000 | 852,952,000 | 908,449,000 | 976,141,000 | 799,738,000 | 890,741,000 | 698,616,000 | 783,870,000 | 822,131,000 | 858,457,000 | 929,079,000 | 998,235,000 | 1,040,126,000 | 614,397,000 | 687,200,000 | 760,600,000 | 557,316,000 | 619,094,000 | 672,042,000 | 557,601,000 | 396,117,000 | 420,065,000 | 449,086,000 | 474,383,000 | 474,336,000 | 491,904,000 | 269,608,000 | 272,030,000 | 181,912,000 | 201,205,000 | 219,069,000 | 111,252,000 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 17,532,000 | 13,726,000 | 16,643,000 | 17,143,000 | 10,035,000 | 11,155,000 | 9,780,000 | 13,271,000 | 11,626,000 | 8,662,000 | 18,616,000 | 10,415,000 | 7,790,000 | 11,551,000 | 16,700,000 | 10,308,000 | 7,654,000 | 51,224,000 | 26,844,000 | 12,853,000 | 15,461,000 | 18,707,000 | 21,896,000 | 21,511,000 | 15,435,000 | 12,413,000 | 17,880,000 | 16,616,000 | 17,320,000 | 17,932,000 | 22,767,000 | 17,899,000 | 23,409,000 | 16,152,000 | 17,106,000 | 15,424,000 | 18,448,000 | 13,746,000 | 14,748,000 | 8,971,000 | 8,914,000 | 12,640,000 | 11,067,000 | 6,225,000 | 5,388,000 | 4,411,000 | 3,678,000 | 2,140,000 | 3,038,000 |
| accrued expenses | 35,289,000 | 20,761,000 | 46,861,000 | 33,307,000 | 36,742,000 | 25,129,000 | 43,167,000 | 30,490,000 | 29,189,000 | 22,459,000 | 30,350,000 | 29,756,000 | 28,383,000 | 19,747,000 | 31,967,000 | 29,234,000 | 36,054,000 | 23,601,000 | 60,140,000 | 49,724,000 | 41,911,000 | 39,631,000 | 53,142,000 | 46,750,000 | 49,218,000 | 37,199,000 | 42,147,000 | 25,303,000 | 25,793,000 | 17,005,000 | 34,031,000 | 30,760,000 | 29,641,000 | 25,114,000 | 32,002,000 | 22,808,000 | 14,414,000 | 12,247,000 | 15,996,000 | 15,985,000 | 11,584,000 | 15,604,000 | 14,020,000 | 10,004,000 | 5,456,000 | 3,841,000 | 6,586,000 | 4,764,000 | 3,586,000 |
| income taxes payable | 683,000 | 871,000 | 52,682,000 | 1,462,000 | 5,257,000 | 5,141,000 | |||||||||||||||||||||||||||||||||||||||||||
| operating lease liabilities | 17,589,000 | 17,196,000 | 16,781,000 | 16,319,000 | 15,860,000 | 15,407,000 | 15,008,000 | 14,664,000 | 14,326,000 | 13,992,000 | 13,663,000 | 13,342,000 | 12,056,000 | 11,744,000 | 10,828,000 | 9,883,000 | 8,932,000 | 7,988,000 | 7,093,000 | 6,881,000 | 6,672,000 | 6,466,000 | 6,642,000 | 7,298,000 | 6,397,000 | 9,128,000 | |||||||||||||||||||||||
| total current liabilities | 70,410,000 | 52,366,000 | 81,156,000 | 119,451,000 | 62,637,000 | 51,691,000 | 67,955,000 | 58,425,000 | 55,141,000 | 45,113,000 | 62,629,000 | 53,596,000 | 48,396,000 | 45,792,000 | 59,826,000 | 57,896,000 | 60,649,000 | 96,504,000 | 94,394,000 | 69,771,000 | 64,353,000 | 69,858,000 | 92,886,000 | 92,432,000 | 89,504,000 | 80,907,000 | 93,503,000 | 84,746,000 | 84,870,000 | 74,699,000 | 94,941,000 | 88,112,000 | 93,648,000 | 82,429,000 | 88,433,000 | 78,003,000 | 67,264,000 | 45,055,000 | 52,888,000 | 49,756,000 | 45,198,000 | 36,379,000 | 61,089,000 | 35,084,000 | 44,638,000 | 34,081,000 | 36,930,000 | 37,377,000 | 36,979,000 |
| operating lease liabilities, net of current portion | 31,171,000 | 35,744,000 | 40,207,000 | 44,515,000 | 48,760,000 | 52,940,000 | 56,988,000 | 60,834,000 | 64,620,000 | 68,346,000 | 71,996,000 | 75,499,000 | 78,946,000 | 82,338,000 | 85,659,000 | 88,840,000 | 91,971,000 | 95,052,000 | 97,458,000 | 99,693,000 | 101,874,000 | 104,010,000 | 106,074,000 | 108,096,000 | 110,073,000 | 66,006,000 | |||||||||||||||||||||||
| other non-current liabilities | 101,000 | 880,000 | 880,000 | 1,156,000 | 1,156,000 | 1,156,000 | 1,156,000 | 1,156,000 | 1,156,000 | 1,313,000 | 3,279,000 | 1,055,000 | 1,055,000 | 2,000 | 3,000 | 262,000 | |||||||||||||||||||||||||||||||||
| total liabilities | 101,682,000 | 88,990,000 | 122,243,000 | 165,122,000 | 112,553,000 | 105,787,000 | 126,099,000 | 120,415,000 | 120,917,000 | 114,772,000 | 137,904,000 | 130,150,000 | 128,397,000 | 128,406,000 | 145,761,000 | 146,736,000 | 152,787,000 | 191,804,000 | 453,452,000 | 427,997,000 | 417,676,000 | 174,439,000 | 250,213,000 | 250,325,000 | 251,193,000 | 201,874,000 | 170,920,000 | 168,866,000 | 175,093,000 | 174,532,000 | 238,894,000 | 237,394,000 | 251,608,000 | ||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 74,000 | 74,000 | 73,000 | 73,000 | 73,000 | 73,000 | 72,000 | 72,000 | 72,000 | 72,000 | 71,000 | 71,000 | 71,000 | 71,000 | 71,000 | 71,000 | 70,000 | 70,000 | 69,000 | 69,000 | 69,000 | 69,000 | 68,000 | 59,000 | 59,000 | 59,000 | 58,000 | 58,000 | 58,000 | 58,000 | 49,000 | 49,000 | 48,000 | 42,000 | 42,000 | 42,000 | 38,000 | 38,000 | 38,000 | 38,000 | 37,000 | 37,000 | 37,000 | 35,000 | 34,000 | 32,000 | 31,000 | 31,000 | 4,000 |
| additional paid-in capital | 2,521,545,000 | 2,506,788,000 | 2,493,811,000 | 2,478,066,000 | 2,464,284,000 | 2,451,620,000 | 2,436,523,000 | 2,421,862,000 | 2,410,905,000 | 2,398,930,000 | 2,386,325,000 | 2,374,755,000 | 2,362,327,000 | 2,351,147,000 | 2,334,348,000 | 2,322,460,000 | 2,306,304,000 | 2,265,713,000 | 2,242,801,000 | 2,225,538,000 | 2,203,599,000 | 2,181,517,000 | 2,156,363,000 | 1,861,523,000 | 1,839,710,000 | 1,818,393,000 | 1,794,283,000 | 1,775,113,000 | 1,743,657,000 | 1,717,609,000 | 1,174,904,000 | 1,160,048,000 | 1,142,233,000 | 857,107,000 | 842,013,000 | 828,043,000 | 652,574,000 | 640,124,000 | 630,078,000 | 619,451,000 | 607,708,000 | 598,494,000 | 591,334,000 | 347,947,000 | 344,490,000 | 246,970,000 | 244,881,000 | 243,601,000 | 2,836,000 |
| accumulated other comprehensive income | 655,000 | 365,000 | 3,420,000 | -1,198,000 | -198,000 | -144,000 | -3,000 | 105,000 | 663,000 | 1,636,000 | 74,000 | 202,000 | 464,000 | 490,000 | 29,000 | 297,000 | 89,000 | 225,000 | 222,000 | 191,000 | -57,000 | 51,000 | 12,000 | 33,000 | 14,000 | 25,000 | |||||||||||||||||||||||
| treasury stock | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -802,486,000 | -783,438,000 | -529,047,000 | ||||||||||||||||||||||||||||||||
| accumulated deficit | -350,233,000 | -238,213,000 | -148,924,000 | -52,401,000 | -1,000,316,000 | -904,198,000 | -822,649,000 | -726,709,000 | -635,385,000 | -551,579,000 | -470,561,000 | -507,087,000 | -425,340,000 | -333,534,000 | -238,760,000 | -144,133,000 | -55,367,000 | -1,843,475,000 | -1,745,818,000 | -1,646,839,000 | -1,556,361,000 | -1,516,105,000 | -1,413,755,000 | -1,307,582,000 | -1,197,711,000 | -1,104,633,000 | -1,012,839,000 | -918,175,000 | -849,430,000 | -798,061,000 | -709,776,000 | -632,639,000 | -549,557,000 | -483,151,000 | -426,665,000 | -363,831,000 | -307,878,000 | -284,680,000 | -244,057,000 | -203,802,000 | -171,905,000 | -166,948,000 | -140,284,000 | -143,988,000 | -125,692,000 | -113,444,000 | -101,062,000 | -89,885,000 | |
| total stockholders’ equity | 1,369,555,000 | 1,466,528,000 | 1,540,956,000 | 1,626,672,000 | 660,510,000 | 743,922,000 | 811,019,000 | 886,843,000 | 964,236,000 | 1,036,526,000 | 1,100,814,000 | 1,050,170,000 | 1,124,070,000 | 1,207,453,000 | 1,291,975,000 | 1,394,762,000 | 1,721,816,000 | 2,296,630,000 | 399,500,000 | 480,452,000 | 558,465,000 | 625,299,000 | 640,528,000 | 448,291,000 | 532,677,000 | 620,257,000 | 687,537,000 | 760,213,000 | 823,142,000 | 865,594,000 | 375,503,000 | 449,806,000 | 508,992,000 | 307,380,000 | 358,591,000 | 401,449,000 | 289,078,000 | 332,373,000 | 345,118,000 | 375,657,000 | 404,165,000 | 426,817,000 | 424,366,000 | 207,749,000 | 200,548,000 | 121,343,000 | 131,482,000 | 142,595,000 | |
| total liabilities and stockholders’ equity | 1,471,237,000 | 1,555,518,000 | 1,663,199,000 | 1,791,794,000 | 773,063,000 | 849,709,000 | 937,118,000 | 1,007,258,000 | 1,085,153,000 | 1,151,298,000 | 1,238,718,000 | 1,180,320,000 | 1,252,467,000 | 1,335,859,000 | 1,437,736,000 | 1,541,498,000 | 1,874,603,000 | 2,488,434,000 | 852,952,000 | 908,449,000 | 976,141,000 | 799,738,000 | 890,741,000 | 698,616,000 | 783,870,000 | 822,131,000 | 858,457,000 | 929,079,000 | 998,235,000 | 1,040,126,000 | 614,397,000 | 687,200,000 | 760,600,000 | 557,316,000 | 619,094,000 | 672,042,000 | 557,601,000 | 396,117,000 | 420,065,000 | 449,086,000 | 474,383,000 | 474,336,000 | 491,904,000 | 269,608,000 | 272,030,000 | 181,912,000 | |||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| commitments and contingent liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2024 and 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -1,518,000 | -1,045,000 | -1,087,000 | -441,000 | -5,896,000 | -8,870,000 | -8,411,000 | -12,535,000 | -15,083,000 | -10,502,000 | -7,745,000 | -484,000 | -2,171,000 | -2,119,000 | -2,398,000 | -2,643,000 | -1,389,000 | -515,000 | -650,000 | -212,000 | -313,000 | -318,000 | -5,000 | ||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at september 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2023 and 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at september 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
| other receivable | 3,774,000 | 2,704,000 | 5,365,000 | 4,378,000 | 6,990,000 | 8,131,000 | |||||||||||||||||||||||||||||||||||||||||||
| financing lease assets | 64,000 | 95,000 | 183,000 | 300,000 | 871,000 | 502,000 | 590,000 | 677,000 | 793,000 | 881,000 | 993,000 | ||||||||||||||||||||||||||||||||||||||
| financing lease liabilities | 83,000 | 167,000 | 250,000 | 331,000 | 412,000 | 839,000 | 321,000 | 317,000 | 313,000 | 309,000 | 306,000 | 273,000 | |||||||||||||||||||||||||||||||||||||
| financing lease liabilities, net of current portion | 276,000 | 276,000 | 167,000 | 248,000 | 331,000 | 412,000 | 491,000 | 571,000 | 673,000 | ||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2022 and 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at september 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue | 2,500,000 | 25,072,000 | 25,072,000 | 25,072,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
| current assets of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
| non-current assets of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
| non-current liabilities of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2021 and 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||
| taxes payable | 8,059,000 | 7,170,000 | 13,370,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at september 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||
| retained earnings | 30,850,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| collaboration receivable – related party | 2,123,000 | 2,334,000 | 2,537,000 | 2,577,000 | 1,539,000 | 1,838,000 | 2,524,000 | 2,319,000 | 2,462,000 | 3,395,000 | 19,326,000 | 3,512,000 | 2,448,000 | 3,489,000 | 4,842,000 | 11,265,000 | 4,886,000 | 8,182,000 | 7,853,000 | 6,814,000 | 8,225,000 | 9,078,000 | 10,474,000 | 7,017,000 | 6,492,000 | 18,759,000 | |||||||||||||||||||||||
| collaboration receivable – other | 1,948,000 | 1,992,000 | 1,827,000 | 2,033,000 | 1,928,000 | 869,000 | 2,222,000 | 1,640,000 | 670,000 | 440,000 | 440,000 | ||||||||||||||||||||||||||||||||||||||
| royalty receivable – related party | 1,650,000 | 3,300,000 | 2,900,000 | 2,600,000 | 2,700,000 | 2,200,000 | 2,234,000 | 1,863,000 | 1,573,000 | 1,417,000 | 1,222,000 | 715,000 | |||||||||||||||||||||||||||||||||||||
| deferred revenue – related party | 4,748,000 | 10,933,000 | 16,873,000 | 18,454,000 | 22,167,000 | 32,710,000 | 42,141,000 | 41,132,000 | 39,212,000 | 37,842,000 | 35,867,000 | 37,069,000 | 37,690,000 | 35,913,000 | 36,415,000 | 31,469,000 | 16,523,000 | 19,665,000 | 22,650,000 | 22,608,000 | 6,886,000 | 35,686,000 | 18,847,000 | ||||||||||||||||||||||||||
| deferred revenue, net of current portion – related party | 50,580,000 | 49,797,000 | 51,616,000 | 54,961,000 | 59,809,000 | 66,294,000 | 72,408,000 | 81,831,000 | 125,798,000 | 134,202,000 | 141,957,000 | 150,596,000 | 154,297,000 | 173,941,000 | 183,540,000 | 1,949,000 | 4,699,000 | 6,240,000 | 9,389,000 | 133,000 | 2,725,000 | 26,352,000 | 26,697,000 | ||||||||||||||||||||||||||
| liability related to the sale of future revenue, net of debt issuance costs | 261,269,000 | 258,121,000 | 250,958,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2020 and 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||
| other assets | 1,350,000 | 1,575,000 | 1,800,000 | 1,382,000 | 838,000 | 611,000 | 678,000 | 660,000 | 640,000 | 590,000 | 454,000 | 455,000 | 467,000 | 4,000 | 11,000 | 1,624,000 | |||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at september 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||
| deferred rent | 766,000 | 686,000 | 625,000 | 550,000 | 301,000 | 3,586,000 | 3,529,000 | 3,473,000 | 3,412,000 | 3,356,000 | 2,933,000 | 2,539,000 | 2,479,000 | 2,150,000 | 2,092,000 | 1,245,000 | 310,000 | 142,000 | 133,000 | 123,000 | 104,000 | ||||||||||||||||||||||||||||
| deferred rent, net of current portion | 17,608,000 | 17,826,000 | 17,815,000 | 18,002,000 | 18,155,000 | 15,080,000 | 16,003,000 | 16,911,000 | 17,773,000 | 18,649,000 | 17,719,000 | 16,740,000 | 17,360,000 | 17,433,000 | 15,631,000 | 11,007,000 | 3,724,000 | 423,000 | 145,000 | 186,000 | 220,000 | 288,000 | |||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2019 and 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at september 30, 2019 and december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2019 and december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2019 and december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2018 and 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at september 30, 2018 and december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2018 and december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2018 and december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||
| tenant improvement and other receivables | 169,000 | 859,000 | 779,000 | 3,452,000 | 3,428,000 | 3,387,000 | 2,014,000 | 571,000 | 3,374,000 | 2,992,000 | 5,282,000 | 6,906,000 | |||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2017 and 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at september 30, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2016 and 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at september 30, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at june 30, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||
| refundable income taxes | 3,841,000 | 3,841,000 | 3,841,000 | 4,496,000 | |||||||||||||||||||||||||||||||||||||||||||||
| other current liabilities | 4,000 | 6,000 | 8,000 | 8,000 | 624,000 | 144,000 | |||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2015 and 2014 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at march 31, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||||||
| other receivables | 2,334,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| restricted cash | 571,000 | 571,000 | 571,000 | 571,000 | 571,000 | ||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding at december 31, 2014 and 2013 | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| unbilled collaboration receivable – related party | |||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue– related party | 33,644,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| unbilled collaboration receivable—related party | 2,619,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue—related party | 25,072,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue, net of current portion—related party | 26,299,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| unbilled collaboration receivable | 476,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| deferred tax assets | 1,246,000 | 1,247,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| liabilities, convertible preferred stock, and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| restricted stock liability | 9,000 | 38,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue, net of current portion | 32,567,000 | 38,835,000 | 45,103,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| restricted stock liability, net of current portion | 6,000 | 10,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value; no shares and 33,188,889 shares authorized, issued and outstanding at december 31, 2013 and 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| series b convertible preferred stock, 0.001 par value; no shares and 5,190,551 shares authorized, issued and outstanding at december 31, 2013 and 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| series c convertible preferred stock, 0.001 par value; no shares and 15,882,389 shares authorized, issued and outstanding at december 31, 2013 and 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 and no shares authorized at december 31, 2013 and 2012, respectively, no shares issued and outstanding. | |||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders’ equity | 201,205,000 | 219,069,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| deferred tax assets, net of current portion | 2,706,000 | 2,706,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| liabilities, convertible preferred stock, and stockholders’ deficit | |||||||||||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value; 0 and 33,188,889 shares authorized, issued and outstanding at september 30, 2013 and december 31, 2012, respectively; aggregate liquidation preference of 0 and 40,973 at september 30, 2013 and december 31, 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| series b convertible preferred stock, 0.001 par value; 0 and 5,190,551 shares authorized, issued and outstanding at september 30, 2013 and december 31, 2012, respectively; aggregate liquidation preference of 0 and 10,232 at september 30, 2013 and december 31, 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| series c convertible preferred stock, 0.001 par value; 0 and 15,882,389 shares authorized, issued and outstanding at september 30, 2013 and december 31, 2012, respectively; aggregate liquidation preference of 0 and 83,252 at september 30, 2013 and december 31, 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 25,000,000 shares authorized at september 30, 2013 and none authorized at december 31, 2012; none issued and outstanding at september 30, 2013 | |||||||||||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value; 33,188,889 shares authorized, issued and outstanding at june 30, 2013 and december 31, 2012; aggregate liquidation preference of 41,969 and 40,973 at june 30, 2013 and december 31, 2012, respectively | 32,940,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| series b convertible preferred stock, 0.001 par value; 5,190,551 shares authorized, issued and outstanding at june 30, 2013 and december 31, 2012; aggregate liquidation preference of 10,491 and 10,232 at june 30, 2013 and december 31, 2012, respectively | 5,681,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| series c convertible preferred stock, 0.001 par value; 15,882,389 shares authorized, issued and outstanding at june 30, 2013 and december 31, 2012; aggregate liquidation preference of 85,592 and 83,252 at june 30, 2013 and december 31, 2012, respectively | 77,301,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ deficit: | |||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ deficit | -87,050,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders’ deficit | 111,252,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| collaboration revenue | 6,268,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| grant revenue | |||||||||||||||||||||||||||||||||||||||||||||||||
| total revenue | 6,268,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||
| research and development | 12,958,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| general and administrative | 1,836,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| total operating expenses | 14,794,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| income from operations | -8,526,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| interest income | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| income before benefit for income taxes | -8,521,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| benefit for income taxes | 99,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| net income | -8,620,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| cumulative preferred stock dividends | -1,798,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| net income applicable to common stockholders | -10,418,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| net income per share | -2,800 | ||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average number of common shares used in net income per share applicable to common stockholders – basic and diluted | 3,722,963,000 |
We provide you with 20 years of balance sheets for Agios Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Agios Pharmaceuticals. Explore the full financial landscape of Agios Pharmaceuticals stock with our expertly curated balance sheets.
The information provided in this report about Agios Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.